Rizatriptan Benzoate
Product Images NDC 50090-4619

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 50090-4619). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure01 (Fig01)

The text appears to be a chart or graph showing the estimated probability of response for two different dosages (5mg and 10mg) of Rizatriptan Benzoate, a medication commonly used to treat migraines. The probability of response is shown as 80% for both dosages.*

FDA Label Image

Figure02 (Fig02)

FDA Label Image

Figure5

FDA Label Image

Label Image (Lbl500904619)

Product No. 6404-0 is referenced, but there is not enough context to provide a useful description. The remaining text is not readable or not in English.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.